BNP Paribas Financial Markets
PRME icon

BNP Paribas Financial Markets’s Prime Medicine PRME Stock Holding History

BNP Paribas Financial Markets’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Buy
66,101
+31,688
+92% +$105K ﹤0.01% 4142
2026
Q1 		$120K Buy
34,413
+24,590
+250% +$93.6K ﹤0.01% 4285
2025
Q4 		$34.1K Sell
9,823
-9,833
-50% -$43.7K ﹤0.01% 4852
2025
Q3 		$109K Sell
19,656
-7,079
-26% -$28.8K ﹤0.01% 4257
2025
Q2 		$66K Sell
26,735
-4,587
-15% -$7.07K ﹤0.01% 4157
2025
Q1 		$62.3K Buy
31,322
+11,226
+56% +$28.6K ﹤0.01% 4213
2024
Q4 		$58.7K Buy
+20,096
New +$70.5K ﹤0.01% 4360

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BNP Paribas Financial Markets's PRME Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Prime Medicine (PRME) stake by 92% in Q2 2026, buying an estimated $105K and bringing the position to 66,101 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #4142.

BNP Paribas Financial Markets first reported a position in PRME in Q4 2024 and has held it in 7 quarters since. 174 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • BNP Paribas Financial Markets held 66,101 shares of Prime Medicine worth $244K as of Q2 2026.
  • BNP Paribas Financial Markets bought 31,688 Prime Medicine shares in Q2 2026, an estimated $105K.
  • Prime Medicine made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4142 holding.
  • BNP Paribas Financial Markets first reported a position in Prime Medicine in Q4 2024 and has held it in 7 quarters since.
  • 174 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.